vs

Side-by-side financial comparison of Sprinklr, Inc. (CXM) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $219.1M, roughly 1.0× Sprinklr, Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 1.3%, a 18.0% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 9.2%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $19.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 6.2%).

Sprinklr is an American software company that develops a software as a service (SaaS) customer experience management (CXM) platform. The company's software, also called Sprinklr, combines different applications for social media marketing, social advertising, content management, collaboration, employee advocacy, customer care, social media research, and social media monitoring.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CXM vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.0× larger
ORGO
$225.6M
$219.1M
CXM
Growing faster (revenue YoY)
ORGO
ORGO
+69.0% gap
ORGO
78.1%
9.2%
CXM
Higher net margin
ORGO
ORGO
18.0% more per $
ORGO
19.4%
1.3%
CXM
More free cash flow
ORGO
ORGO
$15.0M more FCF
ORGO
$34.8M
$19.8M
CXM
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
6.2%
CXM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CXM
CXM
ORGO
ORGO
Revenue
$219.1M
$225.6M
Net Profit
$2.9M
$43.7M
Gross Margin
66.4%
Operating Margin
5.3%
28.1%
Net Margin
1.3%
19.4%
Revenue YoY
9.2%
78.1%
Net Profit YoY
-72.2%
469.5%
EPS (diluted)
$0.01
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXM
CXM
ORGO
ORGO
Q4 25
$219.1M
$225.6M
Q3 25
$212.0M
$150.9M
Q2 25
$205.5M
$101.0M
Q1 25
$202.5M
$86.7M
Q4 24
$200.7M
$126.7M
Q3 24
$197.2M
$115.2M
Q2 24
$196.0M
$130.2M
Q1 24
$194.2M
$110.0M
Net Profit
CXM
CXM
ORGO
ORGO
Q4 25
$2.9M
$43.7M
Q3 25
$12.6M
$21.6M
Q2 25
$-1.6M
$-9.4M
Q1 25
$98.7M
$-18.8M
Q4 24
$10.5M
$7.7M
Q3 24
$1.8M
$12.3M
Q2 24
$10.6M
$-17.0M
Q1 24
$21.1M
$-2.1M
Gross Margin
CXM
CXM
ORGO
ORGO
Q4 25
66.4%
Q3 25
68.2%
Q2 25
69.5%
Q1 25
71.0%
72.6%
Q4 24
71.2%
75.5%
Q3 24
72.6%
76.7%
Q2 24
73.9%
77.6%
Q1 24
75.5%
73.9%
Operating Margin
CXM
CXM
ORGO
ORGO
Q4 25
5.3%
28.1%
Q3 25
7.7%
13.7%
Q2 25
-0.9%
-12.5%
Q1 25
5.2%
-30.9%
Q4 24
3.9%
8.1%
Q3 24
-0.0%
5.4%
Q2 24
2.9%
-10.7%
Q1 24
9.5%
-3.5%
Net Margin
CXM
CXM
ORGO
ORGO
Q4 25
1.3%
19.4%
Q3 25
5.9%
14.3%
Q2 25
-0.8%
-9.3%
Q1 25
48.7%
-21.7%
Q4 24
5.2%
6.1%
Q3 24
0.9%
10.7%
Q2 24
5.4%
-13.1%
Q1 24
10.9%
-1.9%
EPS (diluted)
CXM
CXM
ORGO
ORGO
Q4 25
$0.01
$0.31
Q3 25
$0.05
$0.11
Q2 25
$-0.01
$-0.10
Q1 25
$0.35
$-0.17
Q4 24
$0.04
$0.05
Q3 24
$0.01
$0.09
Q2 24
$0.04
$-0.13
Q1 24
$0.07
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXM
CXM
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$189.6M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$558.1M
$300.1M
Total Assets
$1.1B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXM
CXM
ORGO
ORGO
Q4 25
$189.6M
$93.7M
Q3 25
$125.4M
$63.7M
Q2 25
$126.4M
$73.1M
Q1 25
$145.3M
$110.0M
Q4 24
$93.2M
$135.6M
Q3 24
$119.1M
$94.3M
Q2 24
$126.8M
$89.9M
Q1 24
$164.0M
$88.6M
Total Debt
CXM
CXM
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
CXM
CXM
ORGO
ORGO
Q4 25
$558.1M
$300.1M
Q3 25
$543.4M
$255.1M
Q2 25
$639.8M
$233.2M
Q1 25
$612.1M
$242.9M
Q4 24
$497.0M
$262.9M
Q3 24
$469.0M
$278.5M
Q2 24
$610.9M
$263.5M
Q1 24
$679.7M
$278.0M
Total Assets
CXM
CXM
ORGO
ORGO
Q4 25
$1.1B
$598.7M
Q3 25
$1.1B
$509.8M
Q2 25
$1.2B
$461.1M
Q1 25
$1.2B
$467.4M
Q4 24
$970.3M
$497.9M
Q3 24
$983.8M
$446.3M
Q2 24
$1.1B
$443.2M
Q1 24
$1.2B
$458.5M
Debt / Equity
CXM
CXM
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXM
CXM
ORGO
ORGO
Operating Cash FlowLast quarter
$20.0M
$39.4M
Free Cash FlowOCF − Capex
$19.8M
$34.8M
FCF MarginFCF / Revenue
9.0%
15.4%
Capex IntensityCapex / Revenue
0.1%
2.1%
Cash ConversionOCF / Net Profit
6.87×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXM
CXM
ORGO
ORGO
Q4 25
$20.0M
$39.4M
Q3 25
$34.8M
$3.1M
Q2 25
$83.8M
$-32.9M
Q1 25
$5.4M
$-19.9M
Q4 24
$9.2M
$10.9M
Q3 24
$21.3M
$8.7M
Q2 24
$41.7M
$4.7M
Q1 24
$17.3M
$-10.2M
Free Cash Flow
CXM
CXM
ORGO
ORGO
Q4 25
$19.8M
$34.8M
Q3 25
$34.4M
$844.0K
Q2 25
$83.5M
$-36.5M
Q1 25
$4.6M
$-23.6M
Q4 24
$8.2M
$7.6M
Q3 24
$19.8M
$6.1M
Q2 24
$39.2M
$2.9M
Q1 24
$15.2M
$-12.4M
FCF Margin
CXM
CXM
ORGO
ORGO
Q4 25
9.0%
15.4%
Q3 25
16.2%
0.6%
Q2 25
40.6%
-36.1%
Q1 25
2.3%
-27.2%
Q4 24
4.1%
6.0%
Q3 24
10.1%
5.3%
Q2 24
20.0%
2.2%
Q1 24
7.9%
-11.3%
Capex Intensity
CXM
CXM
ORGO
ORGO
Q4 25
0.1%
2.1%
Q3 25
0.2%
1.5%
Q2 25
0.1%
3.6%
Q1 25
0.4%
4.2%
Q4 24
0.5%
2.7%
Q3 24
0.8%
2.2%
Q2 24
1.3%
1.4%
Q1 24
1.1%
2.0%
Cash Conversion
CXM
CXM
ORGO
ORGO
Q4 25
6.87×
0.90×
Q3 25
2.76×
0.14×
Q2 25
Q1 25
0.05×
Q4 24
0.88×
1.43×
Q3 24
11.58×
0.71×
Q2 24
3.92×
Q1 24
0.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXM
CXM

License And Service$190.3M87%
Professional Services$28.8M13%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons